Tech Company Financing Transactions

Collegium Pharmaceutical Funding Round

TPG Biotech, Adage Capital Management and Aperture Venture Partners joined a $50 million funding round for Collegium Pharmaceutical. The financing round closed on 3/11/2015.

Transaction Overview

Company Name
Collegium Pharmaceutical
Announced On
3/11/2015
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors

TPG Biotech (Lead Investor) (Eran Nadav)

Adage Capital Management

Aperture Venture Partners

Boston Millennia Partners

EcoR1 Capital Management

Eventide Asset Management

Frazier Healthcare Partners (Patrick Heron)

Longitude Capital Management (David Hirsch)

RA Capital

Rock Springs Capital

Skyline Ventures (John Freund)

Proceeds Purpose
Collegium plans to use the proceeds of this financing to advance its lead abuse-deterrent product candidate, Xtampza ER (oxycodone extended-release capsules), through potential FDA approval and commercial launch as well as to fund operational growth and other pipeline development programs.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Technology Center Dr. 300
Stoughton, MA 02072
USA
Phone
(781) 713-3699
Website
www.collegiumpharma.com
Email Address
[email protected]
Overview
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.
Profile
Collegium Pharmaceutical LinkedIn Company Profile
Social Media
Collegium Pharmaceutical Company Twitter Account
Company News
Collegium Pharmaceutical News
Facebook
Collegium Pharmaceutical on Facebook
YouTube
Collegium Pharmaceutical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joseph Ciaffoni
  Joseph Ciaffoni LinkedIn Profile  Joseph Ciaffoni Twitter Account  Joseph Ciaffoni News  Joseph Ciaffoni on Facebook
Chief Financial Officer
Paul Brannelly
  Paul Brannelly LinkedIn Profile  Paul Brannelly Twitter Account  Paul Brannelly News  Paul Brannelly on Facebook
Chief Technical Officer
Alison Fleming
  Alison Fleming LinkedIn Profile  Alison Fleming Twitter Account  Alison Fleming News  Alison Fleming on Facebook
VP - Sales
Scott Dreyer
  Scott Dreyer LinkedIn Profile  Scott Dreyer Twitter Account  Scott Dreyer News  Scott Dreyer on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/11/2015: Zuora venture capital transaction
Next: 3/11/2015: BuildingIQ venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.